PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
January 1, 2013The Medicine Forum144 citationsOpen Access

PROGgene: gene expression based survival analysis web application for multiple cancers

CGChirayu GoswamiHNHarikrishna Nakshatri

Key Points

Key points are not available for this paper at this time.

Abstract

Identification of prognostic mRNA biomarkers has been done for various cancer types. The data that are published from such studies are archived in public repositories. There are hundreds of such datasets available for multiple cancer types in public repositories. Wealth of such data can be utilized to study prognostic implications of mRNA in different cancers as well as in different populations or subtypes of same cancer. We have created a web application that can be used for studying prognostic implications of mRNA biomarkers in a variety of cancers. We have compiled data from public repositories such as GEO, EBI Array Express and The Cancer Genome Atlas for creating this tool. With 64 patient series from 18 cancer types in our database, this tool provides the most comprehensive resource available for survival analysis to date. The tool is called PROGgene and it is available at http://www.compbio.iupui.edu/proggene . We present this tool as a hypothesis generation tool for researchers to identify potential prognostic mRNA biomarkers to follow up with further research. For this reason, we have kept the web application very simple and straightforward. We believe this tool will be useful in accelerating biomarker discovery in cancer and quickly providing results that may indicate disease-specific prognostic value of specific biomarkers.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Goswami et al. (2013) studied this question.

synapsesocial.com/papers/69dbcc11387cf70698688c5ahttps://doi.org/10.1186/2043-9113-3-22
Ask AI
Helpful
Bookmark
Share
View Full Paper

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1High-Risk Ovarian Cancer Based on 126-Gene Expression Signature Is Uniquely Characterized by Downregulation of Antigen Presentation Pathway2012 · 203 citations
  2. 2P1-07-18: Expanding an Online Tool for Genome-Wide Validation of Survival-Associated Biomarkers in Breast and Ovarian Cancer Using Microarray Data of 3,862 Patients.2011 · 71 citations
  3. 3Survival-Related Profile, Pathways, and Transcription Factors in Ovarian Cancer2009 · 179 citations
  4. 4Pancreatic cancer circulating tumour cells express a cell motility gene signature that predicts survival after surgery2012 · 70 citations
  5. 5Akt1 and Akt2: differentiating the aktion.2011 · 81 citations